NCT06924437

Brief Summary

This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three-dimentional tranvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operatve hysteroscopy in different uterine pathologies such as uterine polyps, fibroids, adhesions in addition to mullerian anomalies especially septate uteri.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 6, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

April 6, 2025

Last Update Submit

April 6, 2025

Conditions

Uterine Abnominalies

Outcome Measures

Primary Outcomes (1)

  • 1- accuracy

    Comparing thee- dimentional ultrasonography and office hysteroscopy for uterine cavity evaluation after operatve hysteroscopy as regards accuracy, pain score, and cost-effectiveness of each method.

    one year

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiological females
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

It will be held in the department of Obstetrics and Gynecology during the period from February 2025 to February 2026. The study will include all recruited patients who will be selected for operative hysteroscopy during that period.

You may qualify if:

  • Patients in reproductive age group
  • Patients already selected for operative hysteroscopy
  • Patients accepted to share in the study
  • Patients accepted to come for follow up ( within 3 months after the initial operative procedure, at least after 4 weeks

You may not qualify if:

  • Patients outside the age of reproduction
  • Patients with negative findings at operative hysteroscopy
  • Patients refused to share in the study
  • Patients not available for follow up
  • Infection
  • pregnancy or design of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Mai Allam Abdelmonem, MBbCH

CONTACT

00201015529290maiallam97@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

April 6, 2025

First Posted

April 11, 2025

Study Start

March 31, 2025

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

April 11, 2025

Record last verified: 2025-04